Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher L Corless

Showing results (161-170 of 208) with videos related to

Pageof 21
Sort By:
The Journal of Pathology|May 28, 2005
The gene expression profile of extraskeletal myxoid chondrosarcomaSubbaya Subramanian, Robert B West, Robert J Marinelli, et al.
The American Journal of Pathology|June 25, 2004
The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation statusRobert B West, Christopher L Corless, Xin Chen, et al.
Cancers|January 28, 2026
Genomic and Molecular Associations with Preoperative Immune Checkpoint Inhibition in Patients with Stage III Clear Cell Renal Cell CarcinomaWesley H Chou, Lucy Lawrence, Emma Neham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2006
Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor)Michael C Heinrich, Grant A McArthur, George D Demetri, et al.
Medrxiv : the Preprint Server for Health Sciences|August 6, 2025
Genomic and molecular associations with preoperative immune checkpoint inhibition in patients with stage III clear cell renal cell carcinomaWesley H Chou, Lucy Lawrence, Emma Neham, et al.
Clinical Sarcoma Research|March 15, 2019
Genomic aberrations in cell cycle genes predict progression of <i>KIT</i>-mutant gastrointestinal stromal tumors (GISTs)Michael C Heinrich, Janice Patterson, Carol Beadling, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Clonal evolution of resistance to imatinib in patients with metastatic gastrointestinal stromal tumorsJayesh Desai, Sridhar Shankar, Michael C Heinrich, et al.
Clinical Transplantation|November 21, 2009
Hepatic and cardiac iron overload among patients with end-stage liver disease referred for liver transplantationAvital Y O'Glasser, David L Scott, Christopher L Corless, et al.
Epigenetics|September 28, 2011
A DNA methylation microarray-based study identifies ERG as a gene commonly methylated in prostate cancerJacob Schwartzman, Solange Mongoue-Tchokote, Angela Gibbs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 7, 2006
Molecular correlates of imatinib resistance in gastrointestinal stromal tumorsMichael C Heinrich, Christopher L Corless, Charles D Blanke, et al.
Pageof 21

Showing results (161-170 of 208) with videos related to

Sort By:
Pageof 21
The Journal of Pathology|May 28, 2005
The gene expression profile of extraskeletal myxoid chondrosarcomaSubbaya Subramanian, Robert B West, Robert J Marinelli, et al.
The American Journal of Pathology|June 25, 2004
The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation statusRobert B West, Christopher L Corless, Xin Chen, et al.
Cancers|January 28, 2026
Genomic and Molecular Associations with Preoperative Immune Checkpoint Inhibition in Patients with Stage III Clear Cell Renal Cell CarcinomaWesley H Chou, Lucy Lawrence, Emma Neham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2006
Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor)Michael C Heinrich, Grant A McArthur, George D Demetri, et al.
Medrxiv : the Preprint Server for Health Sciences|August 6, 2025
Genomic and molecular associations with preoperative immune checkpoint inhibition in patients with stage III clear cell renal cell carcinomaWesley H Chou, Lucy Lawrence, Emma Neham, et al.
Clinical Sarcoma Research|March 15, 2019
Genomic aberrations in cell cycle genes predict progression of <i>KIT</i>-mutant gastrointestinal stromal tumors (GISTs)Michael C Heinrich, Janice Patterson, Carol Beadling, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Clonal evolution of resistance to imatinib in patients with metastatic gastrointestinal stromal tumorsJayesh Desai, Sridhar Shankar, Michael C Heinrich, et al.
Clinical Transplantation|November 21, 2009
Hepatic and cardiac iron overload among patients with end-stage liver disease referred for liver transplantationAvital Y O'Glasser, David L Scott, Christopher L Corless, et al.
Epigenetics|September 28, 2011
A DNA methylation microarray-based study identifies ERG as a gene commonly methylated in prostate cancerJacob Schwartzman, Solange Mongoue-Tchokote, Angela Gibbs, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 7, 2006
Molecular correlates of imatinib resistance in gastrointestinal stromal tumorsMichael C Heinrich, Christopher L Corless, Charles D Blanke, et al.
Pageof 21